Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Lucian Radu Chirieac, M.D.

Co-Author

This page shows the publications co-authored by Lucian Chirieac and Massimo Loda.
Connection Strength

0.597
  1. The ubiquitin-specific protease USP2a prevents endocytosis-mediated EGFR degradation. Oncogene. 2013 Mar 28; 32(13):1660-9.
    View in: PubMed
    Score: 0.126
  2. Met activation in non-small cell lung cancer is associated with de novo resistance to EGFR inhibitors and the development of brain metastasis. Am J Pathol. 2010 Jul; 177(1):415-23.
    View in: PubMed
    Score: 0.109
  3. Lung adenocarcinoma with EGFR amplification has distinct clinicopathologic and molecular features in never-smokers. Cancer Res. 2009 Nov 01; 69(21):8341-8.
    View in: PubMed
    Score: 0.105
  4. Clinical significance of TTF-1 protein expression and TTF-1 gene amplification in lung adenocarcinoma. J Cell Mol Med. 2009 Aug; 13(8B):1977-1986.
    View in: PubMed
    Score: 0.103
  5. Immunohistochemical markers associated with brain metastases in patients with nonsmall cell lung carcinoma. Cancer. 2008 Oct 15; 113(8):2129-38.
    View in: PubMed
    Score: 0.098
  6. A comprehensive analysis of PAX8 expression in human epithelial tumors. Am J Surg Pathol. 2011 Jun; 35(6):816-26.
    View in: PubMed
    Score: 0.029
  7. Mutation-specific antibodies for the detection of EGFR mutations in non-small-cell lung cancer. Clin Cancer Res. 2009 May 01; 15(9):3023-8.
    View in: PubMed
    Score: 0.025
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.